Pharma Journalist 9038 posts 0 comments

Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) for the treatment of adult…
Read More...

Merck, known as MSD outside the United States and Canada, and Pfizer Inc. announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that…
Read More...

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes…
Read More...

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future…
Read More...

London – Arena International announced today the first ever Direct-to-Patient and Virtual Clinical Trials (https://arena-international.com/dtpvirtual/) will be held as a Digital…
Read More...

Monopar Therapeutics Inc. and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced a 50/50 collaboration to develop potential Radio-Immuno-Therapeutics (RITs) to treat severe…
Read More...

Eli Lilly and Company announced that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of…
Read More...

ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase platform to develop the cell line essential to the manufacturing of Phylex's…
Read More...

Magenta Therapeutics and Beam Therapeutics announced a non-exclusive research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Magenta’s novel…
Read More...

The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH…
Read More...